Shenzhen Kaifa Technology
920029
Shanghai Yongli Belting
300230
Guomai Culture & Media
301052
4
WuHan Hvsen Biotechnology
300871
5
CHANGFU CO.,LTD
871396
US Stock MarketDetailed Quotes
LYEL Lyell Immunopharma
- 0.541
- -0.052-8.83%
Close Mar 28 16:00 ET
- 0.541
- 0.0000.00%
Post 20:01 ET
159.78MMarket Cap-0.41P/E (TTM)
0.620High0.537Low615.13KVolume0.591Open0.594Pre Close338.09KTurnover0.31%Turnover RatioLossP/E (Static)295.23MShares3.14552wk High0.42P/B109.08MFloat Cap0.48152wk Low--Dividend TTM201.56MShs Float19.840Historical High--Div YieldTTM14.07%Amplitude0.481Historical Low0.549Avg Price1Lot Size
Lyell Immunopharma Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -32.17%370.53M | -32.17%370.53M | -23.44%440.55M | -17.56%491.12M | -14.11%526.3M | -14.67%546.22M | -14.67%546.22M | -11.22%575.43M | -9.12%595.75M | -0.19%612.77M |
| -Cash and cash equivalents | -27.50%105.6M | -27.50%105.6M | -64.96%100.3M | -40.53%133.42M | 14.83%125.65M | 17.88%145.65M | 17.88%145.65M | 146.08%286.21M | 9.06%224.37M | -50.84%109.43M |
| -Short-term investments | -33.86%264.93M | -33.86%264.93M | 17.64%340.25M | -3.68%357.7M | -20.40%400.65M | -22.46%400.58M | -22.46%400.58M | -45.62%289.22M | -17.44%371.38M | 28.63%503.34M |
| Other current assets | 7.14%9.07M | 7.14%9.07M | -16.85%9.5M | -18.35%8.71M | -32.37%7.87M | -24.05%8.46M | -24.05%8.46M | -1.64%11.42M | -4.92%10.66M | -1.39%11.63M |
| Total current assets | -31.57%379.59M | -31.57%379.59M | -23.31%450.05M | -17.58%499.82M | -14.45%534.17M | -14.83%554.69M | -14.83%554.69M | -11.05%586.85M | -9.05%606.41M | -0.21%624.4M |
| Non current assets | ||||||||||
| Net PPE | -48.75%72.94M | -48.75%72.94M | -16.13%124.71M | -15.72%130.79M | -15.19%136.53M | -14.40%142.32M | -14.40%142.32M | -12.43%148.7M | -10.02%155.19M | -6.09%160.99M |
| -Gross PPE | -25.96%143.62M | -25.96%143.62M | -16.13%124.71M | -15.72%130.79M | -15.19%136.53M | -2.36%193.96M | -2.36%193.96M | -12.43%148.7M | -10.02%155.19M | -6.09%160.99M |
| -Accumulated depreciation | -36.85%-70.68M | -36.85%-70.68M | ---- | ---- | ---- | -59.48%-51.65M | -59.48%-51.65M | ---- | ---- | ---- |
| Investments and advances | -34.00%32.01M | -34.00%32.01M | -28.54%39.11M | -72.44%19M | -78.93%19M | -57.84%48.51M | -57.84%48.51M | -62.13%54.73M | -61.36%68.95M | -66.74%90.18M |
| Other non current assets | 39.68%6.31M | 39.68%6.31M | 13.66%5.35M | -5.75%4.53M | -7.35%4.52M | -8.89%4.52M | -8.89%4.52M | 47.38%4.71M | 20.32%4.8M | 26.93%4.88M |
| Total non current assets | -43.04%111.27M | -43.04%111.27M | -18.72%169.17M | -32.60%154.32M | -37.49%160.06M | -31.76%195.34M | -31.76%195.34M | -34.45%208.14M | -35.49%228.94M | -42.64%256.05M |
| Total assets | -34.55%490.86M | -34.55%490.86M | -22.11%619.22M | -21.69%654.14M | -21.15%694.22M | -20.00%750.03M | -20.00%750.03M | -18.65%794.99M | -18.24%835.35M | -17.88%880.45M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 169.17%12.97M | 169.17%12.97M | -17.62%3.6M | -27.67%4.2M | -14.62%4.9M | 22.98%4.82M | 22.98%4.82M | -8.97%4.37M | 36.68%5.81M | -11.94%5.73M |
| -accounts payable | 11.40%5.37M | 11.40%5.37M | -17.62%3.6M | -27.67%4.2M | -14.62%4.9M | 22.98%4.82M | 22.98%4.82M | -8.97%4.37M | 36.68%5.81M | -11.94%5.73M |
| -Other payable | --7.6M | --7.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Current accrued expenses | 76.93%10.13M | 76.93%10.13M | -2.17%29.01M | 3.37%25.67M | 11.14%24.91M | -10.84%5.73M | -10.84%5.73M | 25.81%29.65M | 16.06%24.83M | -1.19%22.42M |
| Current debt and capital lease obligation | 27.12%7.97M | 27.12%7.97M | ---- | ---- | ---- | 38.35%6.27M | 38.35%6.27M | ---- | ---- | ---- |
| -Current capital lease obligation | 27.12%7.97M | 27.12%7.97M | ---- | ---- | ---- | 38.35%6.27M | 38.35%6.27M | ---- | ---- | ---- |
| Other current liabilities | 13.46%3.48M | 13.46%3.48M | -13.37%907K | -73.09%1.01M | -3.93%2.54M | -54.25%3.07M | -54.25%3.07M | -91.02%1.05M | -59.30%3.75M | -53.01%2.65M |
| Current liabilities | 55.82%53.79M | 55.82%53.79M | -4.43%33.51M | -10.21%30.88M | 5.05%32.35M | -6.78%34.52M | -6.78%34.52M | -31.54%35.06M | -31.62%34.39M | -24.99%30.8M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -10.37%50.99M | -10.37%50.99M | -12.18%51.44M | -11.45%53.32M | -10.78%55.16M | -9.93%56.89M | -9.93%56.89M | -9.38%58.58M | -8.86%60.22M | -8.37%61.83M |
| -Long term capital lease obligation | -10.37%50.99M | -10.37%50.99M | -12.18%51.44M | -11.45%53.32M | -10.78%55.16M | -9.93%56.89M | -9.93%56.89M | -9.38%58.58M | -8.86%60.22M | -8.37%61.83M |
| Other non current liabilities | -11.22%3.25M | -11.22%3.25M | -5.59%3.57M | -11.55%3.44M | -11.25%3.55M | -10.92%3.66M | -10.92%3.66M | -10.67%3.78M | -10.41%3.89M | -10.15%4M |
| Total non current liabilities | -10.42%54.25M | -10.42%54.25M | -11.78%55.01M | -11.46%56.76M | -10.81%58.71M | -9.99%60.56M | -9.99%60.56M | -41.19%62.35M | -37.96%64.11M | -56.06%65.83M |
| Total liabilities | 13.63%108.04M | 13.63%108.04M | -9.13%88.52M | -11.02%87.64M | -5.76%91.06M | -8.85%95.08M | -8.85%95.08M | -38.05%97.42M | -35.89%98.5M | -49.37%96.62M |
| Shareholders'equity | ||||||||||
| Share capital | 16.00%29K | 16.00%29K | 4.00%26K | 4.00%26K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K |
| -common stock | 16.00%29K | 16.00%29K | 4.00%26K | 4.00%26K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K | 0.00%25K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -34.23%-1.35B | -34.23%-1.35B | -21.49%-1.15B | -23.41%-1.11B | -27.36%-1.06B | -30.57%-1B | -30.57%-1B | -25.04%-949.18M | -30.41%-898.33M | -27.88%-834.44M |
| Paid-in capital | 4.25%1.73B | 4.25%1.73B | 2.13%1.68B | 2.32%1.68B | 2.72%1.67B | 3.04%1.66B | 3.04%1.66B | 3.70%1.65B | 4.62%1.64B | 5.31%1.62B |
| Gains losses not affecting retained earnings | 409.57%291K | 409.57%291K | 164.35%760K | 83.31%-397K | 89.58%-404K | 98.76%-94K | 98.76%-94K | 88.19%-1.18M | 71.51%-2.38M | 41.23%-3.88M |
| Total stockholders'equity | -41.55%382.82M | -41.55%382.82M | -23.92%530.7M | -23.12%566.5M | -23.05%603.16M | -21.40%654.95M | -21.40%654.95M | -14.93%697.57M | -15.11%736.86M | -11.06%783.83M |
| Total equity | -41.55%382.82M | -41.55%382.82M | -23.92%530.7M | -23.12%566.5M | -23.05%603.16M | -21.40%654.95M | -21.40%654.95M | -14.93%697.57M | -15.11%736.86M | -11.06%783.83M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025